Search

Displaying results 21 - 30 of 2690 in total
  1. Drug

    Azathioprine

    go.drugbank.com/drugs/DB00993
    ApprovedInvestigational

    [L11214] Azathiprine was granted FDA approval on 20 March 1968.[L11214]

    Products: AZATHIOPRIN AL 25MG FTA, AZATHIOPRIN AL 50MG FTA
  2. Drug

    Valsartan

    go.drugbank.com/drugs/DB00177
    ApprovedInvestigational

    Valsartan belongs to the angiotensin II receptor blocker (ARB) family of drugs, which also includes [telmisartan], [candesartan], [losartan], [olmesartan], and [irbesartan]. … The angiotensin II receptor blocker (ARB) family of drugs unique in that it blocks all angiotensin II activity, regardless of where or how it was synthesized.

    Mixtures: EXFORGE 5MG/80MG FTA, EXFORGE 5MG/80MG FTACategories: Angiotensin 2 Receptor Blocker, Angiotensin Receptor Antagonists
  3. Drug

    Pitavastatin

    go.drugbank.com/drugs/DB08860
    ApprovedInvestigational

    Pitavastatin, also known as the brand name product Livalo, is a lipid-lowering drug belonging to the statin class of medications. By inhibiting the endogenous production of cholesterol within the liver, statins lower abnormal cholesterol...

    Products: LIVAZO 1MG FTA, LIVAZO 2MG FTA
  4. Drug

    Losartan

    go.drugbank.com/drugs/DB00678
    ApprovedInvestigational

    [L7423] Losartan was granted FDA approval on 14 April 1995.[L7423] … Losartan is an angiotensin II receptor blocker (ARB) used to treat hypertension.

    Mixtures: LOSAMLO 50MG/5MG FTA, LOSAMLO 50MG/5MG FTACategories: Angiotensin 2 Receptor Blocker, Angiotensin II receptor antagonists
  5. Drug

    Anastrozole

    go.drugbank.com/drugs/DB01217
    ApprovedInvestigational

    including anastrozole, have become endocrine drugs of choice in the treatment of postmenopausal breast cancer due to a more favourable efficacy and adverse effect profile as compared to earlier estrogen receptor

    Products: ANASTROPUREN 1MG FTA, ANASTROZOL BETA 1MG FTA
  6. Drug

    Lamivudine

    go.drugbank.com/drugs/DB00709
    ApprovedInvestigational

    A reverse transcriptase inhibitor and zalcitabine analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat Human Immunodeficiency Virus Type 1 (HIV-1) and hepatitis B (HBV).

    Products: EPIVIR 300MG FTA, LAMIVUDIN TEVA 150MG FTA
  7. Drug

    Moclobemide

    go.drugbank.com/drugs/DB01171
    ApprovedInvestigational

    A reversible monoamine oxidase inhibitor (MAOI) selective for isoform A (RIMA) used to treat major depressive disorder. Most meta-analyses and most studies indicate that in the acute management of depression, moclobemide is more efficaci...

    Products: MOCLOBEMID RATIO 150MG FTA, MOCLOBEMID RATIO 300MG FTA
  8. Drug

    Bosentan

    go.drugbank.com/drugs/DB00559
    ApprovedInvestigational

    Bosentan is a dual endothelin receptor antagonist marketed under the trade name Tracleer by Actelion Pharmaceuticals.

    Categories: Endothelin Receptor AntagonistsProducts: TRACLEER 125MG FTA, BOSENTAN AL 125MG FTA
  9. Drug

    Propranolol

    go.drugbank.com/drugs/DB00571
    ApprovedInvestigational

    [L6901,L6904,L6907] Propranolol was granted FDA approval on 13 November 1967.[L6904]

    Categories: Serotonin Receptor Antagonists, Serotonin 5-HT1 Receptor AntagonistsProducts: PROPRA RATIO 10MG FTA, PROPRA RATIO 40MG FTA
  10. Drug

    Capecitabine

    go.drugbank.com/drugs/DB01101
    ApprovedInvestigational

    Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, that is enzymatically converted to fluorouracil (antimetabolite) in the tumor, wh...

    Products: XELODA 500MG FTA, ECANSYA 500MG FTA